AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Marketing.
In this role Gibb will be responsible for building and leading the sales organisation and strengthening the company's commercial presence.
Gibb has more than 20 years of global sales leadership experience. He has worked as VP of Sales and Marketing at Nortis Biosciences, VP of Global Sales at Araceli Biosciences, VP of Global Sales at Emulate, and held senior sales roles at Thermo Fisher Scientific and Becton Dickinson & Co.
Alif Saleh, AxoSim CEO, said: "We are excited to welcome Stuart as a key member of our team. He has an impressive track record in commercialising and scaling organ-on-a-chip platforms from zero to multi-million-dollar businesses."
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar